In vivo combination treatment with pemetrexed and sildenafil enhanced the anti-tumour efficacy of checkpoint inhibitory antibodies directed against programmed cell death protein 1 (PD-1) or cytotoxic T-lymphocyte-associated protein 4 (CTLA4). The gene discussed is CTLA4; the disease is neoplasm.